Aventis Opposes Plaintiffs' Motion for Interlocutory Appeal




BATON ROUGE, La. - The manufacturer of Arava filed an opposition to the plaintiffs' motion for certification of an interlocutory appeal of a judge's order denying their motion to remand, contending that the plaintiffs' failure to warn claim against the pharmacists who dispensed the drug is not recognized under Louisiana law. Carol Guidry, et al. v. Aventis Pharmaceuticals, et al. No. 03-493 (M.D. La.).

Aventis Pharmaceuticals contended in its motion that under U.S.C. § 1292(b), certification of an interlocutory appeal requires a controlling question of law, substantial ground for difference of opinion, and a question whose immediate appeal may materially …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

April 08, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's Data Breach Litigation Conference

March 26, 2025 - Charlotte, NC
Omni Charlotte Hotel

MORE DETAILS